State
73,722 recalls have nationwide distribution and so reach American Samoa. 25 additional recalls listed American Samoa specifically in their distribution scope.
Of the 25 recalls naming American Samoa we have scored against our rubric, 1 (4%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 9 (36%) are Severe.
Which agencies issued them
These figures cover only the 25 recalls whose distribution notice names American Samoa specifically. The 73,722 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Assurance Infusion is recalling a specific lot of BAC/FENT/MORP injection due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling BUP 23MG/HYDROM 25MG/SUF 100MCG/ML Injection syringes due to a lack of sterility assurance. The recall covers nationwide distribution.
Assurance Infusion is recalling Morphine Sulfate Injection in 20 mL syringes due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling HCG 1,000U/1ML injection vials nationwide due to a lack of sterility assurance. Consumers should stop using the product and contact their healthcare provider.
Assurance Infusion is recalling specific lots of Baclofen and Hydromorphone injection due to a lack of sterility assurance.
Assurance Infusion is recalling BUP 5MG/MORP 10MG/ML Injection in 20 mL syringes due to a lack of sterility assurance. The recall covers lots distributed nationwide.
Assurance Infusion is recalling Fentanyl and Sufentanil Injection in 20 mL syringes due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Buprenorphine and Hydromorphone injection due to a lack of sterility assurance.
Assurance Infusion is recalling 2 syringes of BUP 5MG/HYDROM 15MG/SUF 600MCG/ML injection due to a lack of sterility assurance.
Assurance Infusion is recalling Fentanyl 100mcg/mL injection syringes nationwide due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Morphine 20mg/mL injection syringes nationwide due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Buprenorphine and Morphine injection due to a lack of sterility assurance.
Assurance Infusion is recalling Alprostadil 40 mcg/mL injection vials nationwide due to a lack of sterility assurance.
Assurance Infusion is recalling specific syringes of a Baclofen, Clonidine, and Morphine injection due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Morphine 18mg/mL injection due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling Hydrom 10mg/Suf 200mcg/mL injection syringes due to a lack of sterility assurance. The recall covers nationwide distribution.
Assurance Infusion is recalling BUP 35MG/MORP 10MG/ML Injection syringes due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling BUP 3.5MG/HYDROM 4MG/ML Injection in 20 mL syringes due to a lack of sterility assurance. The recall covers nationwide distribution.
Assurance Infusion is recalling specific lots of BUP 20MG/CLON 250MCG/FENT 7200MCG/ML Injection due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of HCG 3000U/1ML injections because they lack sterility assurance. The recall covers products distributed nationwide.
Assurance Infusion is recalling Fentanyl 800mcg/mL injection syringes due to a lack of sterility assurance. The product was distributed nationwide in the United States.
Assurance Infusion is recalling 358 vials of Trimix Forte injection nationwide due to a lack of sterility assurance.
Assurance Infusion is recalling BUP 1MG//ML/HYDROM 7MG Injection in 20 mL syringes due to a lack of sterility assurance. The recall covers nationwide distribution in the United States.
Assurance Infusion is recalling specific syringes of a multi-drug injection due to a lack of sterility assurance. The affected products were distributed nationwide.
Assurance Infusion is recalling BUP 17MG/MORP 22MG/ML injection syringes due to a lack of sterility assurance.